Trial intelligence / Profile preview

Bisoprolol vs Verapamil in Non-obstructive HCM

NCT05569382Phase 4Recruiting

Start
Aug 2022
Primary completion
Apr 2027
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of bisoprolol, verapamil in hypertrophic cardiomyopathy (HCM). Started Aug 2022; status: recruiting.

02

Drugs

bisoprololverapamil
03

Conditions

hypertrophic cardiomyopathy (HCM)

Beyond the preview

Go deeper on NCT05569382.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05569382.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call